Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement

Practical Radiation Oncology

Volumn 7, Issue 2, 2017, Pages 73-79

  Correa, Candace ^a   Harris, Eleanor E ^b   Leonardi, Maria Cristina ^c   Smith, Benjamin D ^d   Taghian, Alphonse G ^e   Thompson, Alastair M ^d   White, Julia ^f   Harris, Jay R ^g  

^a Faxton St Luke's Healthcare ^*  (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOSENSITIZING AGENT;

AGE; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; EARLY CANCER; FAT NECROSIS; HEALTH CARE PLANNING; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; MEDICAL SOCIETY; POPULATION GROUP; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SURGICAL MARGIN; SYSTEMATIC REVIEW; TELECOMMUNICATION; WHOLE BODY RADIATION; ADULT; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EVIDENCE BASED MEDICINE; FEMALE; MIDDLE AGED; PARTIAL MASTECTOMY; PATIENT SELECTION; PRACTICE GUIDELINE; PROCEDURES; PROSPECTIVE STUDY; STANDARDS; TUMOR RECURRENCE; UNITED STATES;

ADULT; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 85006802982     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2016.09.007     Document Type: Article

References (48)

1. [1] Strnad, V., Ott, O.J., Hildebrandt, G., et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387:10015 (2016), 229–238.
2. [2] Polgar, C., Major, T., Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol 14:1 (2009), 7–24.
3. [3] Polgar, C., Fodor, J., Major, T., Sulyok, Z., Kasler, M., Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108:2 (2013), 197–202.
4. [4] Livi, L., Meattini, I., Marrazzo, L., et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51:4 (2015), 451–463.
5. [5] Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer. https://clinicaltrials.gov/ct2/show/NCT00103181?term=NSABP+B-39%2FRTOG+0413&rank=2 Accessed 10/21/2016.
6. [6] Olivotto, I.A., Whelan, T.J., Parpia, S., et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31:32 (2013), 4038–4045.
7. [7] Ott, O.J., Hildebrandt, G., Potter, R., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiotherapy and oncology journal of the European Society for Therapeutic Radiology and Oncology 82:3 (2007), 281–286.
8. [8] Shah, C., Wilkinson, J.B., Lyden, M., Beitsch, P., Vicini, F.A., Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. International journal of radiation oncology, biology, physics 82:5 (2012), e825–e830.
9. [9] Pashtan, I.M., Recht, A., Ancukiewicz, M., et al. External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys 84:3 (2012), e271–e277.
10. [10] Shah, C., Wilkinson, J.B., Keisch, M., et al. Impact of margin status on outcomes following accelerated partial breast irradiation using single-lumen balloon-based brachytherapy. Brachytherapy 12:2 (2013), 91–98.
11. [11] McCormick, B., Winter, K., Hudis, C., et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:7 (2015), 709–715.
12. [12] Hughes, L.L., Wang, M., Page, D.L., et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:32 (2009), 5319–5324.
13. [13] Solin, L.J., Gray, R., Hughes, L.L., et al. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study. J Clin Oncol 33:33 (2015), 3938–3944.
14. [14] Goyal, S., Vicini, F., Beitsch, P.D., et al. Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194. Cancer 117:6 (2011), 1149–1155.
15. [15] Jeruss, J.S., Kuerer, H.M., Beitsch, P.D., Vicini, F.A., Keisch, M., Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Ann Surg Oncol 18:1 (2011), 65–71.
16. [16] Vicini, F., Shah, C., Ben Wilkinson, J., Keisch, M., Beitsch, P., Lyden, M., Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Ann Surg Oncol 20:4 (2013), 1275–1281.
17. [17] Shah, C., McGee, M., Wilkinson, J.B., et al. Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ. Clin Breast Cancer 12:4 (2012), 259–263.
18. [18] McHaffie, D.R., Patel, R.R., Adkison, J.B., Das, R.K., Geye, H.M., Cannon, G.M., Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Int J Radiat Oncol Biol Phys 81:1 (2011), 46–51.
19. [19] Zauls, A.J., Watkins, J.M., Wahlquist, A.E., et al. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys 82:1 (2012), 21–29.
20. [20] Abbott, A.M., Portschy, P.R., Lee, C., et al. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 87:3 (2013), 494–498.
21. [21] Veronesi, U., Orecchia, R., Maisonneuve, P., et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:13 (2013), 1269–1277.
22. [22] Vaidya, J.S., Wenz, F., Bulsara, M., et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:9917 (2014), 603–613.
23. [23] Leonardi, M.C., Maisonneuve, P., Mastropasqua, M.G., et al. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys 83:3 (2012), 806–813.
24. [24] Vaidya, J.S., Bulsara, M., Wenz, F., et al. Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys 92:3 (2015), 491–497.
25. [25] Cuzick, J., Radiotherapy for breast cancer, the TARGIT-A trial. Lancet, 383(9930), 2014, 1716.
26. [26] Livi, L., Buonamici, F.B., Simontacchi, G., et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys 77:2 (2010), 509–515.
27. [27] Rampinelli, C., Bellomi, M., Ivaldi, G.B., et al. Assessment of pulmonary fibrosis after radiotherapy (RT) in breast conserving surgery: comparison between conventional external beam RT (EBRT) and intraoperative RT with electrons (ELIOT). Technol Cancer Res Treat 10:4 (2011), 323–329.
28. [28] Maluta S, Dall'Oglio S, Goer DA, Marciai N. Intraoperative Electron Radiotherapy (IOERT) as an Alternative to Standard Whole Breast Irradiation: Only for Low-Risk Subgroups? Breast care (Basel, Switzerland). 2014;9(2):102-106.
29. [29] Leonardi, M.C., Maisonneuve, P., Mastropasqua, M.G., et al. Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol 106:1 (2013), 21–27.
30. [30] Sperk, E., Welzel, G., Keller, A., et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat 135:1 (2012), 253–260.
31. [31] Chang, D.W., te Marvelde, L., Chua, B.H., Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer. Int J Radiat Oncol Biol Phys 88:1 (2014), 73–79.
32. [32] Welzel, G., Hofmann, F., Blank, E., et al. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol 17:suppl 3 (2010), 359–367.
33. [33] Kraus-Tiefenbacher, U., Bauer, L., Scheda, A., et al. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys 66:2 (2006), 377–381.
34. [34] Blank, E., Kraus-Tiefenbacher, U., Welzel, G., et al. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays. Ann Surg Oncol 17:suppl 3 (2010), 352–358.
35. [35] Welzel, G., Boch, A., Sperk, E., et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol, 8, 2013, 9.
36. [36] Hepel, J.T., Tokita, M., MacAusland, S.G., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75:5 (2009), 1290–1296.
37. [37] Jagsi, R., Ben-David, M.A., Moran, J.M., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76:1 (2010), 71–78.
38. [38] Chafe, S., Moughan, J., McCormick, B., et al. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer. Int J Radiat Oncol Biol Phys 86:5 (2013), 854–859.
39. [39] Lei, R.Y., Leonard, C.E., Howell, K.T., et al. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat 140:1 (2013), 119–133.
40. [40] Lewin, A.A., Derhagopian, R., Saigal, K., et al. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:5 (2012), 2104–2110.
41. [41] Formenti, S.C., Hsu, H., Fenton-Kerimian, M., et al. Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys 84:3 (2012), 606–611.
42. [42] Rodriguez, N., Sanz, X., Dengra, J., et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 87:5 (2013), 1051–1057.
43. [43] Chen, P.Y., Wallace, M., Mitchell, C., et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 76:4 (2010), 991–997.
44. [44] Reeder, R., Carter, D.L., Howell, K., et al. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 74:1 (2009), 92–97.
45. [45] Vera, R., Trombetta, M., Mukhopadhyay, N.D., Packard, M., Arthur, D., Long-term cosmesis and toxicity following 3-dimensional conformal radiation therapy in the delivery of accelerated partial breast irradiation. Pract Radiat Oncol 4:3 (2014), 147–152.
46. [46] Shaitelman, S.F., Kim, L.H., Grills, I.S., et al. Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 81:3 (2011), 788–794.
47. [47] Leonard, K.L., Hepel, J.T., Hiatt, J.R., Dipetrillo, T.A., Price, L.L., Wazer, D.E., The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 85:3 (2013), 623–629.
48. [48] Mellon, E.A., Sreeraman, R., Gebhardt, B.J., Mierzejewski, A., Correa, C.R., Impact of radiation treatment parameters and adjuvant systemic therapy on cosmetic outcomes after accelerated partial breast irradiation using 3-dimensional conformal radiation therapy technique. Pract Radiat Oncol 4:3 (2014), e159–e166.